Pre-exposure to environmental cues predictive of food availability elicits hypothalamic-pituitary-adrenal axis activation and increases operant responding for food in female rats

Addiction Biology

Volumn 14, Issue 4, 2009, Pages 397-407

  Cifani, Carlo ^a   Zanoncelli, Alessandro ^b   Tessari, Michela ^b   Righetti, Claudio ^b   Di Francesco, Carla ^b   Ciccocioppo, Roberto ^a   Massi, Maurizio ^a   Melotto, Sergio ^b  

^a UNIVERSITY OF CAMERINO   (Italy)

^b GSK   (Italy)

Author keywords

Female rats; Fluoxetine; Food associated cues; Rimonabant; Sibutramine; Topiramate

Indexed keywords

AMYLIN; CORTICOSTERONE; CORTICOTROPIN; FLUOXETINE; GASTRIC INHIBITORY POLYPEPTIDE; GHRELIN; GROWTH HORMONE; INSULIN; LEPTIN; LUTEINIZING HORMONE; PANCREAS POLYPEPTIDE; PEPTIDE YY; PROLACTIN; RIMONABANT; SIBUTRAMINE; THYROID HORMONE; THYROTROPIN; TOPIRAMATE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; CORTICOTROPIN BLOOD LEVEL; DRUG SELF ADMINISTRATION; EATING DISORDER; ENVIRONMENTAL EXPOSURE; EXPERIMENTAL MODEL; EXPERIMENTAL STUDY; FEEDING; FEEDING BEHAVIOR; FEMALE; FOOD AVAILABILITY; FOOD INTAKE; GROWTH HORMONE BLOOD LEVEL; HORMONE BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INSTRUMENTAL CONDITIONING; INSULIN BLOOD LEVEL; LUTEINIZING HORMONE BLOOD LEVEL; NONHUMAN; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; RAT; REINFORCEMENT; SELF CONCEPT; STIMULUS RESPONSE; THYROID GLAND; THYROTROPIN BLOOD LEVEL; WISTAR RAT;

ADRENOCORTICOTROPIC HORMONE; ANIMALS; ANTI-OBESITY AGENTS; APPETITE DEPRESSANTS; CANNABINOIDS; CONDITIONING, OPERANT; CORTICOSTERONE; CUES; CYCLOBUTANES; ENVIRONMENT; FEEDING BEHAVIOR; FEMALE; FLUOXETINE; FRUCTOSE; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MOTIVATION; PIPERIDINES; PITUITARY-ADRENAL SYSTEM; PYRAZOLES; RATS; REPRODUCIBILITY OF RESULTS; SEROTONIN UPTAKE INHIBITORS;

EID: 70049110449     PISSN: 13556215     EISSN: 13691600     Source Type: Journal    
DOI: 10.1111/j.1369-1600.2009.00152.x     Document Type: Article

References (38)

1. American Psychiatric Association (2000) Diagnostic and Statistical Manual of Mental Disorders, IV-TR. Washington, DC : APA.
2. Appolinario JC, McElroy SL (2004) Pharmacological approaches in the treatment of binge eating disorder. Curr Drug Targets 5 : 301 307.
3. van Bronswijk H, Dubois EA, Pijl H, Cohen AF (2007) New drugs; rimonabant. Ned Tijdschr Geneeskd 151 : 2620 2622.
4. Carai M, Colombo G, Gessa GL (2005) Rimonabant: The first therapeutically relevant cannabinoid antagonist. Life Sci 77 : 2339 2350.
5. Carai M, Colombo G, Maccioni P, Gessa GL (2006) Efficacy of Rimonabant and other Cannabinoid CB1 receptor antagonists in reducing food intake and body weight: preclinical and clinical data. CNS Drug Rev 12 : 91 99.
6. Carter WP, Hudson JI, Lalonde JK, Pindyck L, McElroy SL, Pope HG Jr. (2003) Pharmacologic treatment of binge eating disorder. Int J Eat Disord 34 : 74 88.
7. Ciccocioppo R, Sanna PP, Weiss F (2001) Cocaine-predictive stimulus induces drug-seeking behavior and neural activation in limbic brain regions after multiple months of abstinence: reversal by D(1) antagonists. Proc Natl Acad Sci USA 98 : 1976 1981.
8. Cooper PJ, Bowskill R (1986) Dysphoric mood and overeating. Br J Clin Psychol 25 : 155 156.
9. Corwin RL, Buda-Levin A (2004) Behavioral models of binge-type eating. Physiol Behav 82 : 123 130.
10. Crowther JH, Sanftner J, Bonifazi DZ, Shepherd KL (2001) The role of daily hassles in binge eating. Int J Eat Disord 29 : 449 454.
11. Devlin MJ, Goldfein JA, Petkova E, Jiang H, Raizman PS, Wolk S (2005) Cognitive behavioral therapy and fluoxetine as adjuncts to group behavioral therapy for binge eating disorder. Obes Res 13 : 1077 1088.
12. Economidou D, Mattioli L, Cifani C, Perfumi M, Massi M, Cuomo V, Trabace L, Ciccocioppo R (2006) Effect of the cannabinoid CB1 receptor antagonist SR-141716A on ethanol self-administration and ethanol-seeking behaviour in rats. Psychopharmacology 183 : 394 403.
13. Ghitza UE, Gray SM, Epstein DH, Rice KC, Shaham Y (2006) The anxiogenic drug yohimbine reinstates palatable food seeking in a rat relapse model: a role of CRF1 receptors. Neuropsychopharmacology 31 : 2188 2196.
14. Gluck ME (2006) Stress response and binge eating disorder. Appetite 46 : 26 30.
15. Grilo CM, Masheb RM (2005) A randomized controlled comparison of guided self-help cognitive behavioral therapy and behavioral weight loss for binge eating disorder. Behav Res Ther 43 : 1509 1525.
16. Grilo CM, Masheb RM, Salant SL (2005) Cognitive behavioral therapy guided self-help and orlistat for the treatment of binge eating disorder: A randomized, double-blind, placebo-controlled trial. Biol Psychiatry 57 : 1193 1201.
17. Hansson AC, Cippitelli A, Sommer WH, Fedeli A, Bjork K, Soverchia L, Terasmaa A, Massi M, Heilig M, Ciccocioppo R (2006) Variation at the rat Crhr1 locus and sensitivity to relapse into alcohol seeking induced by environmental stress. Proc Natl Acad Sci USA 103 : 15236 15241.
18. Herman CP, Polivy J (1975) Anxiety, restraint, and eating behavior. J Abnorm Psychol 84 : 66 72.
19. Hetherington MM, Altemus M, Nelson ML, Bernay AS, Gold PW (1994) Eating behavior in bulimia nervosa: Multiple meal analysis. Am J Clin Nutr 60 : 864 873.
20. Hudson J, Hiripi E, Pope HG Jr., Kessler RC (2007) The prevalence and correlates of eating disorders in the National Comorbidity Survey Replication. Biol Psychiatry 61 : 348 358.
21. Jesudason D, Wittert G (2008) Endocannabinoid system in food intake and metabolic regulation. Curr Opin Lipidol 19 : 344 348.
22. Johnson BA, Ait-Daoud N, Bowden CL, DiClemente CC, Roache JD, Lawson K (2003) Oral topiramate for treatment of alcohol dependence: A randomised controlled trial. Lancet 361 : 1677 1685.
23. Kampman KM, Pettinati H, Lynch KG, Dackis C, Sparkman T, Weigley C, O'Brien CP (2004) A pilot trial of topiramate for the treatment of cocaine dependence. Drug Alcohol Depend 75 : 233 240.
24. Kjelsas E, Bjornstrom C, Gotestam KG (2004) Prevalence of eating disorders in female and male adolescents (14-15 years). Eat Behav 5 : 13 25.
25. Koob GF, Le Moal M (1997) Drug abuse: hedonic homeostatic dysregulation. Science 278 : 52 58.
26. McElroy SL, Hudson JI, Capece JA, Beyers K, Fisher AC, Rosenthal NR (2007) Topiramate for the treatment of binge eating disorder associated with obesity: a placebo-controlled study. Biol Psychiatry 61 : 1039 1048.
27. McElroy SL, Hudson JI, Malhotra S, Welge JA, Nelson EB, Keck PE Jr. (2003) Citalopram in the treatment of binge-eating disorder: a placebo-controlled trial. J Clin Psychiatry 64 : 807 813.
28. McElroy SL, Shapira NA, Arnold LM, Keck PE, Rosenthal NR, Wu SC (2004) Topiramate in the long-term treatment of binge-eating disorder associated with obesity. J Clin Psychiatry 65 : 1463 1469.
29. Mizes JS (1985) Bulimia: A review of its symptomatology and treatment. Adv Behav Res Ther 7 : 91 142.
30. Padwal RS, Majumdar SR (2007) Drug treatments for obesity: orlistat, sibutramine, and rimonabant. Lancet 369 : 71 77.
31. Polivy J, Herman CP (1985) Dieting and binging. A causal analysis. Am Psychol 40 : 193 201.
32. Rogers PJ, Smit HJ (2000) Food craving and food 'addiction': a critical review of the evidence from a biopsychosocial perspective. Pharmacol Biochem Behav 66 : 3 14.
33. Sarnyai Z, Shaham Y, Heinrichs SC (2001) The role of corticotropin- releasing factor in drug addiction. Pharmacol Rev 53 : 209 243.
34. Shapiro JR, Berkman ND, Brownley KA, Sedway JA, Lohr KN, Bulik CM (2007) Bulimia nervosa treatment: a systematic review of randomized controlled trials. Int J Eat Disord May 40 : 321 336.
35. Spitzer RL, Stunkard A, Yanovski S, Marcus MD, Wadden T, Wing R, Mitchell J, Hasin D (1993a) Binge eating disorder should be included in DSM-IV: a reply to Fairburn et al. s 'the classification of recurrent overeating: the binge eating disorder proposal. Int J Eat Disord 13 : 161 169.
36. Spitzer RL, Yanovski S, Wadden T, Wing R, Marcus MD, Stunkard A, Devlin M, Mitchell J, Hasin D, Horne RL (1993b) Binge eating disorder: its further validation in a multisite study. Int J Eat Disord 13 : 137 153.
37. Striegel-Moore RH, Silberstein LR, Rodin J (1986) Toward an understanding of risk factors for bulimia. Am Psychol 41 : 246 263.
38. Wilfley DE, Welch RR, Stein RI, Spurrell EB, Cohen LR, Saelens BE (2002) A randomized comparison of group cognitive-behavioral therapy and group interpersonal psychotherapy for the treatment of overweight individuals with binge-eating disorder. Arch Gen Psychiatry 59 : 713 721.